🤑 It doesn’t get more affordable. Grab this 60% OFF Black Friday offer before it disappears…CLAIM SALE

$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying

Published 04/06/2024, 14:11
Updated 04/06/2024, 15:40
© Reuters.  $4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying
XRAY
-
WTFC
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Although U.S. stocks closed mixed on Monday, there were a few notable insider trades.

When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.

Below is a look at a few recent notable insider purchases. For more, check out Benzinga’s insider transactions platform.

DENTSPLY SIRONA

  • The Trade: DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Gregory T Lucier acquired a total of 3,577 shares at an average price of $27.95. To acquire these shares, it cost around $99,976.
  • What's Happening: On May 2, the company reported adjusted earnings per share of 42 cents, in line with the street view.
  • What DENTSPLY SIRONA Does: Dentsply Sirona is one of the world’s largest manufacturers of dental equipment and supplies.
CARGO Therapeutics
  • The Trade: CARGO Therapeutics, Inc. (NASDAQ:CRGX) 10% owner Srinivas Akkaraju acquired a total of 294,000 shares at an average price of $17.00. To acquire these shares, it cost around $5 million.
  • What's Happening: On May 28, CARGO Therapeutics announced it entered into a securities purchase agreement for a private investment in public equity financing that is expected to result in gross proceeds of approximately $110.0 million.
  • What CARGO Therapeutics Does: Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients.
Wintrust Financial
  • The Trade: Wintrust Financial Corporation (NASDAQ:WTFC) Director, Founder and Senior Advisor Edward J Wehmer bought a total of 1,197 shares at an average price of $24.64. To acquire these shares, it cost around $29,489.
  • What's Happening: On April 17, Wintrust Finl posted upbeat quarterly earnings.
  • What Wintrust Financial Does: Wintrust Financial Corp is a financial holding company operating in the Chicago metropolitan area and southern Wisconsin through its wholly-owned banking subsidiaries.
Read More: Top 3 Utilities Stocks That May Plunge In Q2

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.